BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by dateSort by citations
Year Range
to
Clear all filters

All Papers

16+ results
Field: Metabolism, Diabetes, and Cancer

Role of Insulin in Health and Disease: An Update

Verified

Md Saidur Rahman, Khandkar Shaharina Hossain, Sharnali Das, Sushmita Kundu et al.

Journal: International Journal of Molecular Sciences
Year: 2021
Citations: 435

Insulin is a polypeptide hormone mainly secreted by β cells in the islets of Langerhans of the pancreas. The hormone potentially coordinates with glucagon to modulate blood glucose levels; insulin acts via an anabolic pathway, while glucagon performs catabolic functions. Insulin regulates glucose le...

Health SciencesMedicineSurgeryOpen Access
Read Source

Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study

Verified

Patricio López‐Jaramillo, Diego Gómez-Arbeláez, Daniel Martínez-Bello, Marc Evans M. Abat et al.

Journal: The Lancet Healthy LongevityYear: 2022Citations: 340

BackgroundThe triglyceride glucose (TyG) index is an easily accessible surrogate marker of insulin resistance, an important pathway in the development of type 2 diabetes and cardiovascular diseases. However, the association of the TyG index with cardiovascular diseases and mortality has mainly been ...

Health SciencesMedicineEndocrinology, Diabetes and MetabolismOpen Access
Read Source

Diabetes Mellitus: Insights from Epidemiology, Biochemistry, Risk Factors, Diagnosis, Complications and Comprehensive Management

Verified

Saruar Alam, Md. Kamrul Hasan, Sharif Neaz, Nazmul Hussain et al.

Journal: DiabetologyYear: 2021Citations: 306

Diabetes mellitus has become a serious and chronic metabolic disorder that results from a complex interaction of genetic and environmental factors, principally characterized by hyperglycemia, polyuria, and polyphagia. Uncontrolled high blood sugar can result in a host of diabetic complications. Prol...

Health SciencesMedicineEndocrinology, Diabetes and MetabolismOpen Access
Read Source

Recessive mutations in the <i>INS</i> gene result in neonatal diabetes through reduced insulin biosynthesis

Verified

Intza Garin, Emma L. Edghill, İldem Akerman, Oscar Rubio‐Cabezas et al.

Journal: Proceedings of the National Academy of SciencesYear: 2010Citations: 209

Heterozygous coding mutations in the INS gene that encodes preproinsulin were recently shown to be an important cause of permanent neonatal diabetes. These dominantly acting mutations prevent normal folding of proinsulin, which leads to beta-cell death through endoplasmic reticulum stress and apopto...

Health SciencesMedicineSurgeryOpen Access
Read Source

Hypoglycaemic activity of <i>Coccinia indica</i> and <i>Momordica charantia</i> in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase

Verified

Biazid Alam Shibib, Laazina Khan, R Rahman

Journal: Biochemical JournalYear: 1993Citations: 206

Coccinia indica leaves were extracted with 60% ethanol, solvents were evaporated and the residue was suspended in water. This suspension was administered orally at a dose of 200 mg/kg body wt. after 18 h of fasting to normal fed and streptozotocin-induced male diabetic rats (180-250 g). After 90 min...

Health SciencesMedicineEndocrinology, Diabetes and MetabolismOpen Access
Read Source

Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes

Verified

Siddhartha Dutta, Rima Shah, Shubha Singhal, Sudeshna Banerjee Dutta et al.

Journal: Drug Design Development and TherapyYear: 2023Citations: 201

Metformin has been designated as one of the most crucial first-line therapeutic agents in the management of type 2 diabetes mellitus. Primarily being an antihyperglycemic agent, metformin also has a plethora of pleiotropic effects on various systems and processes. It acts majorly by activating AMPK ...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular BiologyOpen Access
Read Source

Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects

Verified

Muhamad Noor Alfarizal Kamarudin, Md. Moklesur Rahman Sarker, Jin‐Rong Zhou, Ishwar S. Parhar

Journal: Journal of Experimental & Clinical Cancer ResearchYear: 2019Citations: 192

Growing evidence showed the increased prevalence of cancer incidents, particularly colorectal cancer, among type 2 diabetic mellitus patients. Antidiabetic medications such as, insulin, sulfonylureas, dipeptyl peptidase (DPP) 4 inhibitors and glucose-dependent insulinotropic peptide (GLP-1) analogue...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular BiologyOpen Access
Read Source

Type 2 diabetes in rural and urban population: diverse prevalence and associated risk factors in Bangladesh

Verified

Akhtar Hussain, Muhammad Abdur Rahim, Abul Kalam Azad Khan, S Ali et al.

Journal: Diabetic MedicineYear: 2005Citations: 166

AIMS: To describe differences in prevalence of Type 2 diabetes mellitus with its associated risk factors between rural and urban populations in Bangladesh. Diagnostic criteria [fasting blood glucose (FBG) and oral glucose tolerance tests (OGTT)] were compared and reviewed for both populations. METHO...

Health SciencesMedicineEndocrinology, Diabetes and Metabolism
Read Source

Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32

Verified

Pamela J. Goodwin, Wendy R. Parulekar, Karen A. Gelmon, Lois E. Shepherd et al.

Journal: JNCI Journal of the National Cancer InstituteYear: 2015Citations: 131

BACKGROUND: Metformin may improve metabolic factors (insulin, glucose, leptin, highly sensitive C-reactive protein [hs-CRP]) associated with poor breast cancer outcomes. The NCIC Clinical Trials Group (NCIC CTG) MA.32 investigates effects of metformin vs placebo on invasive disease-free survival and...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular BiologyOpen Access
Read Source

Action of Phytochemicals on Insulin Signaling Pathways Accelerating Glucose Transporter (GLUT4) Protein Translocation

Verified

Abu Sadat Md. Sayem, Aditya Arya, Hamed Karimian, Narendiran Krishnasamy et al.

Journal: MoleculesYear: 2018Citations: 119

Diabetes is associated with obesity, generally accompanied by a chronic state of oxidative stress and redox imbalances which are implicated in the progression of micro- and macro-complications like heart disease, stroke, dementia, cancer, kidney failure and blindness. All these complications rise pr...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular BiologyOpen Access
Read Source

Diabetes and Impaired Fasting Glycemia in a Rural Population of Bangladesh

Verified

M Abu Sayeed, Hajera Mahtab, Parvin Akter Khanam, Zafar Latif et al.

Journal: Diabetes CareYear: 2003Citations: 117

OBJECTIVE: To determine the prevalence of type 2 diabetes and impaired fasting glycemia (IFG) in a rural population of Bangladesh. RESEARCH DESIGN AND METHODS: A cluster sampling of 4,923 subjects >/=20 years old in a rural community were investigated. Fasting plasma glucose, blood pressure, height,...

Health SciencesMedicineEndocrinology, Diabetes and MetabolismOpen Access
Read Source

Incretin hormone mimetics and analogues in diabetes therapeutics

Verified

Brian D. Green, Peter R. Flatt

Journal: Best Practice & Research Clinical Endocrinology & MetabolismYear: 2007Citations: 113

The incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are physiological gut peptides with insulin-releasing and extrapancreatic glucoregulatory actions. Incretin analogues/mimetics activate GLP-1 or GIP receptors whilst avoiding physiological in...

Health SciencesMedicineEndocrinology, Diabetes and Metabolism
Read Source

Metformin: Activation of 5′ AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action

Verified

S. K. Goel, Ravinder Pal Singh, Varinder Singh, Harmanjit Singh et al.

Journal: Frontiers in GeneticsYear: 2022Citations: 95

Metformin is a plant-based drug belonging to the class of biguanides and is known to treat type-2 diabetes mellitus (T2DM). The drug, combined with controlling blood glucose levels, improves the body's response to insulin. In addition, trials have identified the cardioprotective potential of metform...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular BiologyOpen Access
Read Source

AMP-Activated Protein Kinase Alpha 2 Deletion Induces VSMC Phenotypic Switching and Reduces Features of Atherosclerotic Plaque Stability

Verified

Ding Ye, Miao Zhang, Wencheng Zhang, Qiulun Lu et al.

Journal: Circulation ResearchYear: 2016Citations: 95

RATIONALE: AMP-activated protein kinase (AMPK) has been reported to play a protective role in atherosclerosis. However, whether AMPKα2 controls atherosclerotic plaque stability remains unknown. OBJECTIVE: The aim of this study was to evaluate the impact of AMPKα2 deletion on atherosclerotic plaque s...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular BiologyOpen Access
Read Source

Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2APpp2r2d

Verified

Biny K. Joseph, Hsing‐Yin Liu, Jamie Francisco, Devanshi Pandya et al.

Journal: Journal of Biological ChemistryYear: 2015Citations: 91

AMP kinase is a heterotrimeric serine/threonine protein kinase that regulates a number of metabolic processes, including lipid biosynthesis and metabolism. AMP kinase activity is regulated by phosphorylation, and the kinases involved have been uncovered. The particular phosphatases counteracting the...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular BiologyOpen Access
Read Source
PreviousPage 1 of 2+Next